CBX7 and acute myeloid leukemia: In addition, pretreatment with CBX7 inhibitors showed a trend toward reduced infiltration of hCD45+ AML cells in the spleen (Figure 6D,F) and reduced engraftment of hCD45+ AML cells in the BM (Figure 6E,G).